SPEAKERS
Giorgio Davidoni, VP Human Resources, Eli Lilly China
Giorgio joined Eli Lilly Italia in March 1996 as Human Resources Manager for Manufacturing. After a couple of years, he moved to Eli Lilly Corporate Centre in Indianapolis where he work in C&B and HR Strategy He then join the US Affiliate where he covered the position of HR for Sales and Marketing. He then returned to the Italian Affiliate where he took the responsibility of HR Director. Since October 2010 he is VP Human Resources Eli Lilly China. Before joining Eli Lilly, Giorgio worked for Electrolux for four years always in Human Resources. In 1991, Giorgio graduated in law at the University of Trieste where he also got his Master in Business Administration. Giorgio’s personal interests are spending time with his family, wife Laura and 3 boys Alessandro, Andrea, Luca, reading (in particular, books on business, economics and politics) travel and playing golf.
About Lilly
Lilly is a global health care leader that unites caring with discovery to make life better for people around the world. Based in Indianapolis, Indiana, Lilly conducts clinical research in more than 55 countries and markets products in 125. Lilly first established a presence in China in 1918 and has been expanding in the country since the early 1990s. Today, there are 4,000 Lilly employees in China – more than in any other country outside the U.S. Lilly products that treat infection, diabetes, cancer, diseases of the central nervous system, and other conditions helped an estimated 12 million Chinese patients in 2013. Lilly China is based in Shanghai, with offices in Beijing and in many provinces. Lilly has two manufacturing facilities in Suzhou, focusing on diabetes medicines, antibiotics, and central nervous system medicines, and a diabetes research center in Shanghai. Lilly is the first global pharmaceutical company to create a venture capital fund focused on China and has a history of collaborations with companies and universities in China. Lilly’s goal is to become a corporate citizen that is “In China, For China.” In March 2011, Lilly China received a “Special Contribution Award” from the Ministry of Health (MoH) for Lilly’s ongoing efforts to fight multidrug-resistant tuberculosis and for its close collaboration with the MoH and Chinese communities.